Physician
Internal Medicine
Dr. Debra S. Birnkrant, MD
|
|
Give Review
Debra S. Birnkrant is an expert in the field of Internal Medicine. Debra S. Birnkrant, MD is a published MD as well. He has 21 publications published. The latest was: Thalidomide for aphthous ulcers in HIV infection.
Publications
- Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
- FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and r...
- Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects.
- Earlier Sustained Virologic Response Endpoints for Regulatory Approval and Dose Selection of Hepatitis C Therapies.
- Interferon responsiveness does not change in treatment-experienced hepatitis C subjects: implications for drug development and clinical decisions.
- Use of ribavirin to treat influenza.
- Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir: review of cases from the FDA's Adverse Event Reporting System.
- Thalidomide for aphthous ulcers in HIV infection.
- CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.
- Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
- Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues.
- The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
- Antiviral Information Management System (AIMS): a prototype for operational innovation in drug development.
- Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A.
- Regulatory toxicology perspectives on the development of botanical drug products in the United States.
- The use of colposcopy in assessing vaginal irritation in research.
- Running a tightrope: regulatory challenges in the development of antiretrovirals.
- Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.
- Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration''s Adverse Event Reporting System.
- Reporting of deaths during pre-approval clinical trials for advanced HIV-infected populations.
Schools
Temple University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Ning Guo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanwaljit K. Nagi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Negash Ayele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose F. Bonelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahmoud Doski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mordecai M. Gerstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suganthi A. Veerappan, MD |
|
|
Dr. Ashish K. Tolia, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shrinivas Hebsur, MD |
|
|
Dr. Morvarid Alaghmand, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nakul Goyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tahmina K. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milena M. Lolic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira J. Berkower, MD |
|
|
Dr. Phick H. Ng, MD |
|
|
Dr. Olivia N. Johnson, MD |
|
|
Dr. Husna R. Baksh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sushama N. Sreekumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie G. Beitz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|